FDA/DEA Consider Changing Hydrocodone Products to Schedule II
The FDA and DEA are considering whether to change products like Vicodin containing hydrocodone from Schedule III to Schedule II as a means of deterring diversion and drug abuse.
A report from the NACDS on January 24, 2013 states:
"An FDA advisory panel will meet Jan. 24 and 25 to discuss regulation of certain painkillers that contain the opioid hydrocodone. Topics considered will include whether to reclassify some of these drugs, such as Vicodin (hydrocodone plus acetaminophen), into a higher category of danger for misuse or abuse. Other opioid painkillers including Oxycontin and Percocet are already classified in the higher category. The DEA requested that an FDA advisory panel undertake the review and would like the painkillers to be moved to the more tightly controlled Schedule II designation from its current Schedule III designation. An FDA spokesman stated the advisory panel would most likely vote on the issue Jan. 25. At press time, NACDS was prepared to testify against reclassification, emphasizing the need for a zero-tolerance for drug abuse and diversion and a 100-percent commitment to maintaining access to pain medications for legitimate patient-care needs."
The whole story is at: http://consumer.healthday.com/Article.asp?AID=672792.
Is this a necessary step or overkill? What do you think?